Online citations, reference lists, and bibliographies.
← Back to Search

Polysaccharide-Based Nanocarriers For Drug Delivery

Carmen Teijeiro, Adam P. McGlone, Noemi Csaba, M. Garcia-Fuentes, M. Alonso
Published 2014 · Chemistry

Cite This
Download PDF
Analyze on Scholarcy
Share
This paper references
10.1007/s12033-010-9286-1
Enhanced Gene Delivery Mediated by Low Molecular Weight Chitosan/DNA Complexes: Effect of pH and Serum
Surendra Nimesh (2010)
10.1016/j.ijpharm.2009.07.028
Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery.
N. Csaba (2009)
10.1136/ard.54.5.429
Functions of hyaluronan.
T. Laurent (1995)
10.1016/0169-409X(93)90016-W
Treatment of diseases of the eye with mucoadhesive delivery systems
J. L. Greaves (1993)
10.1167/iovs.07-1077
Novel hyaluronic acid-chitosan nanoparticles for ocular gene therapy.
M. de la Fuente (2008)
10.2147/IJN.S38507
Nanoemulsions coated with alginate/chitosan as oral insulin delivery systems: preparation, characterization, and hypoglycemic effect in rats
X. Li (2013)
10.1016/j.ijpharm.2011.04.003
Facilitated nanoscale delivery of insulin across intestinal membrane models.
Camile B. Woitiski (2011)
10.1016/J.LFS.2006.09.040
Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study.
Fang Zheng (2007)
10.1016/j.biomaterials.2012.09.082
Effects of pH on molecular mechanisms of chitosan-integrin interactions and resulting tight-junction disruptions.
Li-Wen Hsu (2013)
10.1208/s12249-012-9807-2
Insulin-Loaded pH-Sensitive Hyaluronic Acid Nanoparticles Enhance Transcellular Delivery
Lina Han (2012)
10.1016/j.jconrel.2012.07.015
Hyaluronic acid-bearing lipoplexes: physico-chemical characterization and in vitro targeting of the CD44 receptor.
Amélie Dufaÿ Wojcicki (2012)
10.1016/J.CARBPOL.2008.12.010
Synthesis and characterization of low molecular weight hyaluronic acid-based cationic micelles for efficient siRNA delivery
Y. Shen (2009)
10.1021/bm800975j
New generation of hybrid poly/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules.
D. Teijeiro-Osorio (2009)
10.1039/B613872A
Chitosan: a soft interconnect for hierarchical assembly of nano-scale components.
G. Payne (2007)
10.1007/PL00000584
Human enzymatic activities related to the therapeutic administration of chitin derivatives
R. Muzzarelli (1997)
10.1016/j.jconrel.2012.03.017
Chitosan-based drug nanocarriers: where do we stand?
M. Garcia-Fuentes (2012)
10.1016/j.biomaterials.2011.10.075
Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.
Y. Jin (2012)
10.1016/j.vaccine.2010.06.121
Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.
B. Slütter (2010)
10.1016/j.jconrel.2009.08.018
Relationship between structure and adjuvanticity of N,N,N-trimethyl chitosan (TMC) structural variants in a nasal influenza vaccine.
N. Hagenaars (2009)
10.1016/j.biomaterials.2012.09.027
Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery.
Tianyue Jiang (2012)
10.1007/s11095-006-9570-8
Efficacy and Mechanism of Action of Chitosan Nanocapsules for Oral Peptide Delivery
C. Prego (2006)
10.1016/S0378-5173(96)04847-8
Evaluation of the biological properties of soluble chitosan and chitosan microspheres
B. Carreño-Gómez (1997)
10.1016/j.ejps.2013.05.008
Hyaluronan nanocapsules as a new vehicle for intracellular drug delivery.
F. Oyarzun-Ampuero (2013)
10.1016/J.EJPB.2003.09.006
Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice.
A. Vila (2004)
10.1016/j.ijpharm.2011.04.049
A novel tumor-targeted delivery system with hydrophobized hyaluronic acid-spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery.
Y. Shen (2011)
10.1016/j.colsurfb.2010.10.019
Chitosan nanocapsules: Effect of chitosan molecular weight and acetylation degree on electrokinetic behaviour and colloidal stability.
M. J. Santander-Ortega (2011)
10.1016/S0928-0987(03)00178-7
The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa.
A. M. de Campos (2003)
10.1016/S0065-2776(08)60537-4
CD44 and its interaction with extracellular matrix.
J. Lesley (1993)
10.1007/s11095-010-0263-y
Hyaluronic Acid/Chitosan-g-Poly(ethylene glycol) Nanoparticles for Gene Therapy: An Application for pDNA and siRNA Delivery
M. Raviña (2010)
10.1016/j.jconrel.2010.07.072
Photochemical internalization (PCI)-mediated enhancement of gene silencing efficiency of polymethacrylates and N,N,N-trimethylated chitosan (TMC) based siRNA polyplexes.
Amir K. Varkouhi (2010)
10.1002/cmdc.200800234
Efficient Cellular Labeling by CD44 Receptor‐Mediated Uptake of Cationic Liposomes Functionalized with Hyaluronic Acid and Loaded with MRI Contrast Agents
G. Esposito (2008)
10.1016/j.biomaterials.2008.12.066
In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery.
K. Sonaje (2009)
10.1016/j.biomaterials.2009.07.017
The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway.
Hu-Lin Jiang (2009)
10.1146/ANNUREV.NUTR.22.011602.092259
How host-microbial interactions shape the nutrient environment of the mammalian intestine.
L. Hooper (2002)
10.1016/j.ejps.2011.10.003
Adjuvanted, antigen loaded N-trimethyl chitosan nanoparticles for nasal and intradermal vaccination: adjuvant- and site-dependent immunogenicity in mice.
S. Bal (2012)
10.1016/j.ejpb.2009.06.002
Design for optimization of nanoparticles integrating biomaterials for orally dosed insulin.
Camile B. Woitiski (2009)
10.1016/j.ejpb.2010.01.010
A comparative study of chitosan and chitosan/cyclodextrin nanoparticles as potential carriers for the oral delivery of small peptides.
A. Trapani (2010)
10.1021/bc1003789
Gene silencing activity of siRNA polyplexes based on thiolated N,N,N-trimethylated chitosan.
Amir K. Varkouhi (2010)
10.1016/j.fct.2013.05.032
Immunostimulatory and antiangiogenic activities of low molecular weight hyaluronic acid.
Chunlin Ke (2013)
10.1016/j.actbio.2009.04.021
Improving chitosan-mediated gene transfer by the introduction of intracellular buffering moieties into the chitosan backbone.
C. Moreira (2009)
10.1016/j.biomaterials.2013.03.065
Hyaluronic acid (HA) presentation as a tool to modulate and control the receptor-mediated uptake of HA-coated nanoparticles.
Abdulaziz Almalik (2013)
10.1016/S0378-5173(01)00760-8
Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A.
A. M. de Campos (2001)
10.1016/J.BIOMATERIALS.2005.05.028
Self-assembled nanoparticles based on glycol chitosan bearing hydrophobic moieties as carriers for doxorubicin: in vivo biodistribution and anti-tumor activity.
Jae Hyung Park (2006)
10.1002/jbm.b.31161
Chitosan-NAC nanoparticles as a vehicle for nasal absorption enhancement of insulin.
X. Wang (2009)
10.1007/s11095-008-9648-6
Chitosan-Thiamine Pyrophosphate as a Novel Carrier for siRNA Delivery
T. Rojanarata (2008)
10.1016/j.addr.2009.09.004
Biodegradation, biodistribution and toxicity of chitosan.
T. Kean (2010)
10.1016/j.actbio.2009.03.007
Colloidal carrier integrating biomaterials for oral insulin delivery: Influence of component formulation on physicochemical and biological parameters.
Camile B. Woitiski (2009)
10.1021/jf305329n
Improved physical and in vitro digestion stability of a polyelectrolyte delivery system based on layer-by-layer self-assembly alginate-chitosan-coated nanoliposomes.
W. Liu (2013)
10.1007/s11095-010-0103-0
The Development and Mechanism Studies of Cationic Chitosan-Modified Biodegradable PLGA Nanoparticles for Efficient siRNA Drug Delivery
Xudong Yuan (2010)
10.1158/1078-0432.CCR-11-0432
Targeting the Notch Ligand Jagged1 in Both Tumor Cells and Stroma in Ovarian Cancer
A. Steg (2011)
10.1039/B900456D
Self-assembled hyaluronic acid nanoparticles as a potential drug carrier for cancer therapy: synthesis, characterization, and in vivo biodistribution
K. Choi (2009)
10.1166/JNN.2006.429
Chitosan nanocapsules as carriers for oral peptide delivery: effect of chitosan molecular weight and type of salt on the in vitro behaviour and in vivo effectiveness.
C. Prego (2006)
10.1016/j.carbpol.2013.04.098
Preparation and characterization of oligochitosan-tragacanth nanoparticles as a novel gene carrier.
A. Fattahi (2013)
10.1021/mp4000053
Preventative vaccine-loaded mannosylated chitosan nanoparticles intended for nasal mucosal delivery enhance immune responses and potent tumor immunity.
Wenjun Yao (2013)
10.1371/journal.pone.0060190
Alginic Acid-Coated Chitosan Nanoparticles Loaded with Legumain DNA Vaccine: Effect against Breast Cancer in Mice
Z. Liu (2013)
10.2147/IJN.S35567
Low molecular weight chitosan conjugated with folate for siRNA delivery in vitro: optimization studies
J. Fernandes (2012)
10.1081/DDC-120016684
Evaluation of the Mucoadhesive Properties of N-Trimethyl Chitosan Chloride
D. Snyman (2003)
10.1016/j.jconrel.2013.09.012
Co-delivery of viral proteins and a TLR7 agonist from polysaccharide nanocapsules: a needle-free vaccination strategy.
Sara Vicente (2013)
10.1016/S0005-2736(01)00362-5
Mechanism of cell transfection with plasmid/chitosan complexes.
T. Ishii (2001)
10.1021/mp2000428
Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes.
H. S. Qhattal (2011)
10.1016/S0168-3659(02)00411-X
Mucoadhesive properties of carbopol or chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats.
H. Takeuchi (2003)
10.1016/j.carbpol.2012.09.029
Mucoadhesive nanoparticles made of thiolated quaternary chitosan crosslinked with hyaluronan.
Y. Zambito (2013)
10.1016/S0168-3659(01)00294-2
Chitosan nanoparticles as delivery systems for doxorubicin.
K. Janes (2001)
10.1096/fasebj.6.9.1612287
Supramolecular organization of extracellular matrix glycosaminoglycans, in vitro and in the tissues
J. Scott (1992)
10.1593/NEO.03460
Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal Doxorubicin in syngeneic and human xenograft mouse tumor models.
D. Peer (2004)
10.1016/J.JCONREL.2007.02.011
Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels.
H. Lee (2007)
10.1021/BM0703923
Oral bioavailability of insulin contained in polysaccharide nanoparticles.
B. Sarmento (2007)
10.1021/bm1013525
Effect of chitosan chain architecture on gene delivery: comparison of self-branched and linear chitosans.
J. Malmo (2011)
10.1080/10611860400011943
Gene Transfer with Three Amphiphilic Glycol Chitosans—the Degree of Polymerisation is the Main Controller of Transfection Efficiency
I. Uchegbu (2004)
10.2147/IJN.S43683
Development and characterization of chitosan-PEG-TAT nanoparticles for the intracellular delivery of siRNA
M. Malhotra (2013)
10.1016/j.biomaterials.2013.01.072
The effect of crosslinking agents on the transfection efficiency, cellular and intracellular processing of DNA/polymer nanocomplexes.
H. Zheng (2013)
10.1016/j.biomaterials.2009.01.054
Optimization strategies for electrospun silk fibroin tissue engineering scaffolds.
Anne J Meinel (2009)
10.1016/J.JCONREL.2005.12.015
Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree.
C. Prego (2006)
10.1016/J.LFS.2007.02.037
The magic glue hyaluronan and its eraser hyaluronidase: a biological overview.
K. Girish (2007)
10.1016/j.jconrel.2010.01.007
Conjugation of ovalbumin to trimethyl chitosan improves immunogenicity of the antigen.
B. Slütter (2010)
10.1023/A:1018908705446
Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles
R. Fernández-Urrusuno (2004)
10.1016/S0092-8674(00)80151-8
Solution Structure of the Link Module: A Hyaluronan-Binding Domain Involved in Extracellular Matrix Stability and Cell Migration
D. Kohda (1996)
10.1016/J.ADDR.2005.07.006
Comparison of the mucoadhesive properties of various polymers.
V. Grabovac (2005)
10.1038/7385
Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy
K. Roy (1999)
10.1016/j.jconrel.2010.04.005
Pegylated poly-l-arginine derivatives of chitosan for effective delivery of siRNA.
S. Noh (2010)
10.1155/2013/574136
Chitosan Combined with Poly-L-arginine as Efficient, Safe, and Serum-Insensitive Vehicle with RNase Protection Ability for siRNA Delivery
Samarwadee Plianwong (2013)
10.1021/la304575x
Hyaluronic acid nanoparticles titrate the viscoelastic properties of viscosupplements.
A. Fakhari (2013)
10.1016/j.addr.2010.03.011
Tumor delivery of macromolecular drugs based on the EPR effect.
V. Torchilin (2011)
10.1074/JBC.M003030200
Identification of the Hyaluronan Receptor for Endocytosis (HARE)*
Bin Zhou (2000)
10.1023/A:1012128907225
Chitosan and Chitosan/Ethylene Oxide-Propylene Oxide Block Copolymer Nanoparticles as Novel Carriers for Proteins and Vaccines
P. Calvo (2004)
10.1208/pt060106
Preparation and characterization of chitosan and trimethyl-chitosanmodified poly-(ε-caprolactone) nanoparticles as DNA carriers
J. Haas (2008)
10.1016/S0168-3659(97)00252-6
DNA-polycation nanospheres as non-viral gene delivery vehicles.
K. Leong (1998)
10.1039/C1JM10466G
Mineralized hyaluronic acid nanoparticles as a robust drug carrier
S. Han (2011)
10.1016/j.biomaterials.2009.09.102
Molecular design of chitosan gene delivery systems with an optimized balance between polyplex stability and polyplex unpacking.
S. Strand (2010)
10.1007/S003960050050
Development of positively charged colloidal drug carriers: Chitosan-coated polyester nanocapsules and submicron-emulsions
P. Calvo (1997)
10.1016/j.biomaterials.2011.10.064
Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin.
H. Cho (2012)
10.1016/j.matbio.2011.11.002
A comprehensive model of hyaluronan turnover in the mouse.
Laurence Jadin (2012)
10.1021/mp200469a
Enhanced oral absorption of hydrophobic and hydrophilic drugs using quaternary ammonium palmitoyl glycol chitosan nanoparticles.
Adeline Siew (2012)
10.1016/J.EJPB.2006.09.005
Probing insulin's secondary structure after entrapment into alginate/chitosan nanoparticles.
B. Sarmento (2007)
10.1016/S0168-3659(00)00361-8
Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency.
H. Mao (2001)
10.1016/j.biomaterials.2011.07.086
Effects of chitosan-nanoparticle-mediated tight junction opening on the oral absorption of endotoxins.
Kiran Sonaje (2011)
10.1021/BM000283N
A hyaluronic acid-taxol antitumor bioconjugate targeted to cancer cells.
Y. Luo (2000)
10.1016/j.vaccine.2010.01.011
Chitosan-based nanoparticles for improving immunization against hepatitis B infection.
C. Prego (2010)
10.1016/j.biomaterials.2011.12.034
The effect of chitosan on transcellular and paracellular mechanisms in the intestinal epithelial barrier.
R. Rosenthal (2012)
10.1021/nn202070n
Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy.
K. Choi (2011)
10.1016/j.biomaterials.2009.10.031
Ultrapure chitosan oligomers as carriers for corneal gene transfer.
E. Klausner (2010)
10.1016/j.carbpol.2012.08.116
Preparation and characterization of nonaarginine-modified chitosan nanoparticles for siRNA delivery.
S. Park (2013)
10.1208/s12249-011-9647-5
Chitosan–Sodium Lauryl Sulfate Nanoparticles as a Carrier System for the In Vivo Delivery of Oral Insulin
A. Elsayed (2011)
10.1177/1091581809337738
Final Report of the Safety Assessment of Hyaluronic Acid, Potassium Hyaluronate, and Sodium Hyaluronate
Lillian C. Becker (2009)
10.1007/s11095-007-9257-9
Chitosan Reduced Gold Nanoparticles as Novel Carriers for Transmucosal Delivery of Insulin
D. Bhumkar (2007)
10.1021/BC050217O
Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26.
Y. Aktaş (2005)
10.1016/j.biomaterials.2010.11.010
PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo.
K. Choi (2011)
10.1021/bc1000609
Efficient gene transfection by histidine-modified chitosan through enhancement of endosomal escape.
Kai-Ling Chang (2010)
10.1074/jbc.M112.349209
The High and Low Molecular Weight Forms of Hyaluronan Have Distinct Effects on CD44 Clustering*
C. Yang (2012)
10.1038/nnano.2007.387
Nanocarriers as an emerging platform for cancer therapy.
D. Peer (2007)
10.1117/1.JBO.17.2.026015
Quantitative 3-D colocalization analysis as a tool to study the intracellular trafficking and dissociation of pDNA-chitosan polyplexes.
N. Reitan (2012)
10.1016/j.jconrel.2011.06.031
Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response.
Shoshy Mizrahy (2011)
10.1016/j.biomaterials.2010.07.086
Enhancement of efficiencies of the cellular uptake and gene silencing of chitosan/siRNA complexes via the inclusion of a negatively charged poly(γ-glutamic acid).
Zi-Xian Liao (2010)
10.1016/j.ejps.2009.08.010
TMC-MCC (N-trimethyl chitosan-mono-N-carboxymethyl chitosan) nanocomplexes for mucosal delivery of vaccines.
B. Sayin (2009)
10.1016/j.biomaterials.2013.03.050
Photo-crosslinked hyaluronic acid nanoparticles with improved stability for in vivo tumor-targeted drug delivery.
H. Yoon (2013)
10.1016/j.biomaterials.2008.12.019
Effects of incorporation of poly(gamma-glutamic acid) in chitosan/DNA complex nanoparticles on cellular uptake and transfection efficiency.
Shu-Fen Peng (2009)
10.1016/j.biomaterials.2012.02.016
Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy.
H. Yoon (2012)
10.1039/C2JM31406A
Amphiphilic hyaluronic acid-based nanoparticles for tumor-specific optical/MR dual imaging
D. Lee (2012)
10.1021/la401166v
Properties and evaluation of quaternized chitosan/lipid cation polymeric liposomes for cancer-targeted gene delivery.
Xiaofei Liang (2013)
10.1016/S1773-2247(12)50016-X
Solid lipid nanoparticles prepared by coacervation method as vehicles for ocular cyclosporine
L. Battaglia (2012)
10.1089/oli.2008.0168
Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells.
S. Taetz (2009)
10.1002/ADFM.201001014
Self‐Assembled pH‐Sensitive Nanoparticles: A Platform for Oral Delivery of Protein Drugs
K. Sonaje (2010)
10.1016/j.ejps.2011.10.001
A step-by-step approach to study the influence of N-acetylation on the adjuvanticity of N,N,N-trimethyl chitosan (TMC) in an intranasal nanoparticulate influenza virus vaccine.
R. Verheul (2012)
10.1080/10837450600940873
Chitosan-DNA Nanoparticles: The Effect of Cell Type and Hydrolysis of Chitosan on In Vitro DNA Transfection
K. Turan (2006)
10.1016/j.biomaterials.2010.05.042
Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: Oral delivery using pH-responsive nanoparticles vs. subcutaneous injection.
K. Sonaje (2010)
10.1038/mt.2010.143
Intracellular trafficking and decondensation kinetics of chitosan-pDNA polyplexes.
M. Thibault (2010)
10.1016/j.jconrel.2009.05.011
Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination.
B. Slütter (2009)
10.1021/bm800298u
Highly efficient system to deliver taxanes into tumor cells: docetaxel-loaded chitosan oligomer colloidal carriers.
M. Lozano (2008)
10.1021/bm302003m
Enzyme responsive hyaluronic acid nanocapsules containing polyhexanide and their exposure to bacteria to prevent infection.
Grit Baier (2013)
10.1016/j.biomaterials.2010.01.089
Folate-PEG coated cationic modified chitosan--cholesterol liposomes for tumor-targeted drug delivery.
H. Wang (2010)
10.1023/B:PHAM.0000022414.17183.58
Novel Chitosan Particles and Chitosan-Coated Emulsions Inducing Immune Response via Intranasal Vaccine Delivery
Takahiro Nagamoto (2004)
10.1016/j.jconrel.2013.02.022
Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo.
H. Han (2013)
10.1016/j.biomaterials.2012.05.013
Elucidating the signaling mechanism of an epithelial tight-junction opening induced by chitosan.
Li-Wen Hsu (2012)
10.1016/j.ijbiomac.2013.04.043
Chitosan-based nanomaterials: a state-of-the-art review.
S. K. Shukla (2013)
10.1016/j.biomaterials.2012.10.013
Synthesis of TAT peptide-tagged PEGylated chitosan nanoparticles for siRNA delivery targeting neurodegenerative diseases.
M. Malhotra (2013)
10.1016/j.yrtph.2009.09.015
The safety of chitosan as a pharmaceutical excipient.
P. Baldrick (2010)
10.1007/s00396-012-2669-z
Chitosan-based nanocapsules: physical characterization, stability in biological media and capsaicin encapsulation
F. Goycoolea (2012)
10.1046/j.1365-2796.1997.00170.x
Hyaluronan: its nature, distribution, functions and turnover
J. E. Fraser (1997)
10.1021/bm101303f
Dendronized chitosan derivative as a biocompatible gene delivery carrier.
Junjie Deng (2011)
10.1016/j.vaccine.2012.06.035
Hepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: Impact of formulation on physicochemical and immunological characteristics.
M. Tafaghodi (2012)
10.1016/j.biomaterials.2011.06.028
Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic® for tumor-targeted delivery of docetaxel.
H. Cho (2011)
10.1021/mp200553x
Dendritic cell targeted chitosan nanoparticles for nasal DNA immunization against SARS CoV nucleocapsid protein.
Dharmendra Raghuwanshi (2012)
10.1016/S0076-6879(09)65015-1
Mucosal delivery of liposome-chitosan nanoparticle complexes.
E. Carvalho (2009)
10.1016/S0168-3659(01)00486-2
Design of biodegradable particles for protein delivery.
A. Vila (2002)
10.1016/0378-5173(95)04280-6
Evaluation of the bioadhesive properties of hyaluronan derivatives: Detachment weight and mucociliary transport rate studies
K. Pritchard (1996)
10.1016/S1773-2247(06)50061-9
Chitosan nanocapsules: a new carrier for nasal peptide delivery
C. Prego (2006)
10.1016/j.canlet.2012.07.002
Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer.
Xiao-yan Yang (2013)
10.1016/J.JCONREL.2005.05.004
Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation.
M. Huang (2005)
10.1016/J.JCONREL.2007.10.013
Gene delivery using chitosan, trimethyl chitosan or polyethylenglycol-graft-trimethyl chitosan block copolymers: establishment of structure-activity relationships in vitro.
Oliver Germershaus (2008)
10.1016/J.UROLONC.2005.08.020
HYTAD1-p20: a new paclitaxel-hyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancer.
A. Rosato (2006)
10.1016/j.biomaterials.2012.05.029
Theranostic nanoparticles based on PEGylated hyaluronic acid for the diagnosis, therapy and monitoring of colon cancer.
K. Choi (2012)
10.1021/mp200572t
Opening of epithelial tight junctions and enhancement of paracellular permeation by chitosan: microscopic, ultrastructural, and computed-tomographic observations.
K. Sonaje (2012)
10.1016/J.EJPS.2005.02.008
A comparative study of the potential of solid triglyceride nanostructures coated with chitosan or poly(ethylene glycol) as carriers for oral calcitonin delivery.
M. Garcia-Fuentes (2005)
10.1055/s-0032-1331165
Preparation and characterization of chitosan/β-cyclodextrin nanoparticles containing plasmid DNA encoding interleukin-12.
M. Nahaei (2013)
10.1016/j.ijpharm.2008.11.013
Chitosan-aprotinin coated liposomes for oral peptide delivery: Development, characterisation and in vivo evaluation.
M. Werle (2009)
10.1016/j.biomaterials.2009.01.017
Factors influencing the transfection efficiency of ultra low molecular weight chitosan/hyaluronic acid nanoparticles.
Nicolas Duceppe (2009)
10.3109/02652048.2012.726279
Preliminary studies on the development of IgA-loaded chitosan–dextran sulphate nanoparticles as a potential nasal delivery system for protein antigens
S. Sharma (2013)
10.1016/J.VACCINE.2006.06.086
N-trimethyl chitosan (TMC) nanoparticles loaded with influenza subunit antigen for intranasal vaccination: biological properties and immunogenicity in a mouse model.
M. Amidi (2007)
10.1007/s11095-005-7676-z
Insulin Containing Nanocomplexes Formed by Self-Assembly from Biodegradable Amine-Modified Poly(Vinyl Alcohol)-Graft-Poly(l-Lactide): Bioavailability and Nasal Tolerability in Rats
M. Simon (2005)
10.1016/j.biomaterials.2010.07.100
Human macrophage activation triggered by chitotriosidase-mediated chitin and chitosan degradation.
C. Gorzelanny (2010)
10.1016/j.actbio.2013.01.039
Enhanced gene delivery by chitosan-disulfide-conjugated LMW-PEI for facilitating osteogenic differentiation.
Xiaoli Zhao (2013)
10.1016/j.ejpb.2012.03.021
Novel thermal-sensitive hydrogel enhances both humoral and cell-mediated immune responses by intranasal vaccine delivery.
Youbin Wu (2012)
10.1016/j.jconrel.2011.07.014
Covalently stabilized trimethyl chitosan-hyaluronic acid nanoparticles for nasal and intradermal vaccination.
R. Verheul (2011)
10.1002/anie.201209991
Supramolecular self-assembled nanoparticles mediate oral delivery of therapeutic TNF-α siRNA against systemic inflammation.
Lichen Yin (2013)
10.1016/J.ADDR.2013.07.001
Polysaccharide-based systems in drug and gene delivery
Y. Wang (2013)
10.1021/ar800274u
Supramolecular interactions in chemomechanical polymers.
H. Schneider (2009)
10.1021/mp300068j
Delivery of peptides to the blood and brain after oral uptake of quaternary ammonium palmitoyl glycol chitosan nanoparticles.
A. Lalatsa (2012)
10.1023/B:PHAM.0000026432.75781.cb
Chitosan Nanoparticles as New Ocular Drug Delivery Systems: in Vitro Stability, in Vivo Fate, and Cellular Toxicity
A. M. de Campos (2004)
10.3892/IJO.17.5.927
Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progression.
H. Li (2000)
10.1088/0957-4484/24/27/275101
Biofunctionalized nanoparticles with pH-responsive and cell penetrating blocks for gene delivery.
V. Gaspar (2013)
10.1021/bm4000713
Ionization behavior of chitosan and chitosan-DNA polyplexes indicate that chitosan has a similar capability to induce a proton-sponge effect as PEI.
I. Richard (2013)
10.1016/j.msec.2012.09.001
Oral insulin delivery by self-assembled chitosan nanoparticles: in vitro and in vivo studies in diabetic animal model.
Piyasi Mukhopadhyay (2013)
10.2147/IJN.S42949
Therapeutic efficiency of folated poly(ethylene glycol)-chitosan-graft-polyethylenimine-Pdcd4 complexes in H-ras12V mice with liver cancer
Youkyoung Kim (2013)
10.1593/NEO.07229
Hyaluronic acid-paclitaxel: antitumor efficacy against CD44(+) human ovarian carcinoma xenografts.
E. Auzenne (2007)
10.1166/JBN.2009.1017
Ionically crosslinked chitosan nanoparticles as gene delivery systems: effect of PEGylation degree on in vitro and in vivo gene transfer.
N. Csaba (2009)
10.3109/03639045.2011.653789
Evaluation of hepatic glucose metabolism via gluconeogenesis and glycogenolysis after oral administration of insulin nanoparticles
Camile B. Woitiski (2012)
10.1016/j.ijpharm.2009.03.032
Low molecular weight chitosan in DNA vaccine delivery via mucosa.
Xiaorong Yang (2009)
10.1039/C2SM07083A
Thermo-responsive transfection of DNA complexes with well-defined chitosan terpolymers
Hongqian Bao (2012)
10.3109/10717541003762888
Nasal and rectal delivery of insulin with chitosan and N-trimethyl chitosan chloride
L. D. du Plessis (2010)
10.1088/0957-4484/19/18/185101
Novel drug nanocarriers combining hydrophilic cyclodextrins and chitosan.
A. Trapani (2008)
10.1016/j.ejpb.2008.09.020
Chitosan/cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro.
D. Teijeiro-Osorio (2009)
10.1016/j.ejpb.2009.06.004
Formulation and characterization of an oily-based system for oral delivery of insulin.
A. Elsayed (2009)
10.1016/j.jconrel.2010.06.009
Dual role of CpG as immune modulator and physical crosslinker in ovalbumin loaded N-trimethyl chitosan (TMC) nanoparticles for nasal vaccination.
B. Slütter (2010)
10.1074/jbc.M608358200
CD44-dependent Intracellular and Extracellular Catabolism of Hyaluronic Acid by Hyaluronidase-1 and -2*
Hosami Harada (2007)
10.1016/J.JCONREL.2006.07.021
Development and characterisation of chitosan nanoparticles for siRNA delivery.
Haliza Katas (2006)
10.1016/S0378-5173(97)00083-5
Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers
P. Calvo (1997)
10.1016/J.JCONREL.2004.07.030
Transmucosal macromolecular drug delivery.
C. Prego (2005)
10.2147/IJN.S30909
Gene-carried hepatoma targeting complex induced high gene transfection efficiency with low toxicity and significant antitumor activity
Qing-Qing Zhao (2012)
10.1002/ADFM.201202503
Components Simulation of Viral Envelope via Amino Acid Modified Chitosans for Efficient Nucleic Acid Delivery: In Vitro and In Vivo Study
Jing Chang (2013)
10.1021/bm900341d
Synthesis of 6-N,N,N-trimethyltriazole chitosan via "click chemistry" and evaluation for gene delivery.
Y. Gao (2009)
10.1007/978-1-4020-8831-5_16
Roles of bioactive sphingolipids in cancer biology and therapeutics.
Sahar A. Saddoughi (2008)
10.1023/B:PHAM.0000012156.65125.01
Anticancer Drug Delivery with Transferrin Targeted Polymeric Chitosan Vesicles
C. Dufès (2004)
10.1007/s11095-012-0961-8
Ternary Polymeric Nanoparticles for Oral siRNA Delivery
J. Zhang (2012)
10.1016/j.biomaterials.2012.06.079
Cationic core-shell liponanoparticles for ocular gene delivery.
M. Jiang (2012)
10.1038/gt.2008.16
Bioadhesive hyaluronan–chitosan nanoparticles can transport genes across the ocular mucosa and transfect ocular tissue
M. Fuente (2008)
10.1074/jbc.M607787200
Expression, Processing, and Glycosaminoglycan Binding Activity of the Recombinant Human 315-kDa Hyaluronic Acid Receptor for Endocytosis (HARE)*
E. N. Harris (2007)
10.1016/j.vetmic.2012.05.035
Mucosal immunization with recombinant influenza hemagglutinin protein and poly gamma-glutamate/chitosan nanoparticles induces protection against highly pathogenic influenza A virus.
Ho-Jin Moon (2012)
10.1002/JPS.21210
Wound healing dressings and drug delivery systems: a review.
J. Boateng (2008)
10.1016/S0168-3659(02)00207-9
Design of poly-ε-caprolactone nanospheres coated with bioadhesive hyaluronic acid for ocular delivery
S. Barbault-Foucher (2002)
10.1016/j.ijpharm.2009.04.014
The complexation between novel comb shaped amphiphilic polyallylamine and insulin: towards oral insulin delivery.
C. Thompson (2009)
10.1155/2012/134607
Synthesis of a new potential conjugated TAT-peptide-chitosan nanoparticles carrier via disulphide linkage
Haliza Katas (2012)
10.1002/ADFM.201301131
Liver-specific and echogenic hyaluronic acid nanoparticles facilitating liver cancer discrimination
Hyun Su Min (2013)
10.1002/jbm.a.33115
Arginine conjugation affects the endocytic pathways of chitosan/DNA nanoparticles.
H. Zhang (2011)
10.1016/0144-8617(95)00157-3
Chitosan-inducing hemorrhagic pneumonia in dogs
S. Minami (1996)
10.1016/J.BIOMATERIALS.2003.12.036
The effect of the degree of chitosan deacetylation on the efficiency of gene transfection.
T. Kiang (2004)
10.1002/mabi.201200409
Polysaccharides and their derivatives for versatile tissue engineering application.
F. Khan (2013)
10.1007/s10529-011-0748-8
Chitosan enhanced gene delivery of cationic liposome via non-covalent conjugation
Bing Wang (2011)
10.1016/j.nano.2011.06.022
Linear polyethylenimine-graft-chitosan copolymers as efficient DNA/siRNA delivery vectors in vitro and in vivo.
S. Tripathi (2012)
10.1016/j.ejps.2012.06.020
Methylated N-(4-N,N-dimethylaminobenzyl) chitosan coated liposomes for oral protein drug delivery.
Jariya Kowapradit (2012)
10.1016/j.biomaterials.2010.12.044
The glucose-lowering potential of exendin-4 orally delivered via a pH-sensitive nanoparticle vehicle and effects on subsequent insulin secretion in vivo.
Ho-Ngoc Nguyen (2011)
10.1007/s11095-006-9136-9
Thiolated Chitosan/DNA Nanocomplexes Exhibit Enhanced and Sustained Gene Delivery
D. Lee (2006)
10.1088/0957-4484/19/7/075105
Design of novel polysaccharidic nanostructures for gene delivery.
M. de la Fuente (2008)
10.1158/1078-0432.CCR-10-0005
Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles
H. Han (2010)
10.1021/bm800832u
Tailoring of chitosans for gene delivery: novel self-branched glycosylated chitosan oligomers with improved functional properties.
S. Strand (2008)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar